• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (75)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Cognitive Disorders  • Neurology, Other  • Psychiatry  • Schizophrenia  • Psychiatry, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Oliver D. Howes, MRCPsych, DM; Andrew J. Montgomery, MRCPsych, PhD; Marie-Claude Asselin, PhD; Robin M. Murray, FRCPsych, DSc; Isabel Valli, MBBS; Paul Tabraham, PhD; Elvira Bramon-Bosch, MRCPsych, PhD; Lucia Valmaggia, PhD; Louise Johns, PhD; Matthew Broome, MRCPsych; Philip K. McGuire, FRCPsych, PhD^*; Paul M. Grasby, MRCPsych, MD^*

Arch Gen Psychiatry. 2009;66(1):13-20.

Context  A major limitation on the development of biomarkers and novel interventions for schizophrenia is that its pathogenesis is unknown. Although elevated striatal dopamine activity is thought to be fundamental to schizophrenia, it is unclear when this neurochemical abnormality develops in relation to the onset of illness and how this relates to the symptoms and neurocognitive impairment seen in individuals with prodromal symptoms of schizophrenia.

Objectives  To determine whether striatal dopamine function is elevated in individuals with prodromal symptoms of schizophrenia before the onset of psychosis and to assess how this relates to the symptoms and neurocognitive impairment.

Design  Case-control study of in vivo striatal dopaminergic function.

Setting  Academic research.

Patients  Patients were recruited from a community mental health service. Twenty-four patients having prodromal symptoms of schizophrenia were compared with 7 patients having schizophrenia and with 12 matched healthy control subjects from the same community.

Main Outcome Measure  Striatal 6-fluoro–L-dopa F 18–dopa uptake measured using positron emission tomographic ¹⁸F-dopa imaging.

Results  Striatal ¹⁸F-dopa uptake was elevated in patients with prodromal symptoms of schizophrenia (effect size, 0.75) to an intermediate degree compared with that in patients with schizophrenia (effect size, 1.25). The elevation was localized in the associative striatum in both groups. Moreover, striatal ¹⁸F-dopa uptake in patients with prodromal symptoms of schizophrenia was correlated with the severity of prodromal psychopathologic and neuropsychological impairment but not with the severity of anxiety or depressive symptoms.

Conclusions  These findings indicate that dopamine overactivity predates the onset of schizophrenia in individuals with prodromal psychotic symptoms, is predominantly localized in the associative striatum, and is correlated with the severity of symptoms and neurocognitive dysfunction.

Author Affiliations: Section of Neuroimaging, Institute of Psychiatry, King's College London (Drs Howes, Murray, Tabraham, Bramon-Bosch, Valmaggia, Johns, Broome, and McGuire and Ms Valli), OASIS (Outreach and Support in South London), South London and Maudsley National Health Service Trust (Drs Howes, Valli, Tabraham, Bramon-Bosch, Valmaggia, Johns, Broome, and McGuire), and Medical Research Council Clinical Sciences Centre (Drs Howes, Montgomery, and Grasby) and Hammersmith Imanet (Dr Asselin), Hammersmith Hospital, London, England. *Drs McGuire and Grasby contributed equally to this article.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Is Elevated Striatal Dopamine Function a Prodromal Sign of Schizophrenia?
Andor E. Simon and Daniel Umbricht
Arch Gen Psychiatry. 2009;66(8):916-917.
EXTRACT | FULL TEXT  

RELATED ARTICLE

This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2009;66(1):9.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transition to Psychosis Associated With Prefrontal and Subcortical Dysfunction in Ultra High-Risk Individuals
Allen et al.
Schizophr Bull 2012;0:sbr194v1-sbr194.
ABSTRACT | FULL TEXT  

Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar-Poli and Meyer-Lindenberg
Schizophr Bull 2012;0:sbr180v1-sbr180.
ABSTRACT | FULL TEXT  

Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations
Howes et al.
Schizophr Bull 2012;0:sbr195v1-sbr195.
ABSTRACT | FULL TEXT  

Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia
Sorg et al.
Schizophr Bull 2012;0:sbr184v1-sbr184.
ABSTRACT | FULL TEXT  

Striatal Dopamine Transporter Availability in Drug-Naive Patients With Schizophrenia: A Case-Control SPECT Study With [99mTc]-TRODAT-1 and a Meta-analysis
Chen et al.
Schizophr Bull 2011;0:sbr163v1-sbr163.
ABSTRACT | FULL TEXT  

A Neural Model of the Loss of Self in Schizophrenia
Taylor
Schizophr Bull 2011;37:1229-1247.
ABSTRACT | FULL TEXT  

Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia
Koychev et al.
J Psychopharmacol 2011;25:1207-1225.
ABSTRACT | FULL TEXT  

Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia - relationship with COMT Val108/158 Met polymorphism, gender and symptomatology
Boot et al.
J Psychopharmacol 2011;25:888-895.
ABSTRACT | FULL TEXT  

Abnormal Relationship Between Medial Temporal Lobe and Subcortical Dopamine Function in People With an Ultra High Risk for Psychosis
Allen et al.
Schizophr Bull 2011;0:sbr017v1-sbr017.
ABSTRACT | FULL TEXT  

Emotion Recognition in Individuals at Clinical High-Risk for Schizophrenia
Amminger et al.
Schizophr Bull 2011;0:sbr015v1-sbr015.
ABSTRACT | FULL TEXT  

Regional brain activation/deactivation during word generation in schizophrenia: fMRI study
John et al.
Br. J. Psychiatry 2011;198:213-222.
ABSTRACT | FULL TEXT  

Presynaptic Regulation of Dopamine Transmission in Schizophrenia
Lyon et al.
Schizophr Bull 2011;37:108-117.
ABSTRACT | FULL TEXT  

Prefrontal Function at Presentation Directly Related to Clinical Outcome in People at Ultrahigh Risk of Psychosis
Fusar-Poli et al.
Schizophr Bull 2011;37:189-198.
ABSTRACT | FULL TEXT  

Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis: A Multimodal Imaging Study
Fusar-Poli et al.
Arch Gen Psychiatry 2010;67:683-691.
ABSTRACT | FULL TEXT  

Positron Emission Tomography in Schizophrenia: A New Perspective
Patel et al.
JNM 2010;51:511-520.
ABSTRACT | FULL TEXT  

Who Is at Risk for a Psychotic Disorder?
Heckers
Schizophr Bull 2009;35:847-850.
ABSTRACT | FULL TEXT  

Is Elevated Striatal Dopamine Function a Prodromal Sign of Schizophrenia?
Simon and Umbricht
Arch Gen Psychiatry 2009;66:916-917.
FULL TEXT  

A Roadmap to Psychosis
JWatch Psychiatry 2009;2009:2-2.
FULL TEXT